These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31550193)

  • 1. Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention.
    Hartmann M; Lanham M; Palanee-Phillips T; Mathebula F; Tolley EE; Peacock D; Pascoe L; Zissette S; Roberts ST; Wagner D; Wilson E; Ayub A; Wilcher R; Montgomery ET;
    AIDS Educ Prev; 2019 Oct; 31(5):433-451. PubMed ID: 31550193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
    AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability and feasibility of the CHARISMA counseling intervention to support women's use of pre-exposure prophylaxis: results of a pilot study.
    Wilson EK; Wagner LD; Palanee-Phillips T; Roberts ST; Tolley EE; Mathebula F; Pascoe L; Lanham M; Wilcher R; Montgomery ET;
    BMC Womens Health; 2021 Mar; 21(1):126. PubMed ID: 33766006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in relationships, HIV risk, and feelings towards PrEP: findings from a qualitative explanatory study among participants in the CHARISMA intervention trial.
    Hartmann M; Triplett N; Roberts ST; Lanham M; Reddy K; Tenza S; Mayisela N; Mbewe D; Maboa O; Mampuru L; Tolley EE; Palanee-Phillips T; Montgomery ET
    BMC Womens Health; 2023 Aug; 23(1):440. PubMed ID: 37608373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study.
    Montgomery ET; Roberts ST; Reddy K; Tolley E; Hartmann M; Wilson E; Mathebula F; Wagner LD; Zissette S; Lanham M; Wilcher R; Baeten JM; Palanee-Phillips T
    AIDS Behav; 2022 Mar; 26(3):752-763. PubMed ID: 34546473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
    Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
    Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "You Never Know What Could Happen": Women's Perspectives of Pre-Exposure Prophylaxis in the Context of Recent Intimate Partner Violence.
    Willie TC; Keene DE; Kershaw TS; Stockman JK
    Womens Health Issues; 2020; 30(1):41-48. PubMed ID: 31537431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
    Pleasants E; Tauya T; Reddy K; Mirembe BG; Woeber K; Palanee-Phillips T; Zimba C; Atujuna M; Montgomery ET;
    AIDS Behav; 2020 Mar; 24(3):866-880. PubMed ID: 31111297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and initial validation of a simple tool to screen for partner support or opposition to HIV prevention product use.
    Tolley EE; Zissette S; Martinez A; Palanee-Phillips T; Mathebula F; Tenza S; Hartmann M; Montgomery ET
    PLoS One; 2020; 15(12):e0242881. PubMed ID: 33351805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intimate Partner Violence and Pre-exposure Prophylaxis (PrEP): A Rapid Review of Current Evidence for Women's HIV Prevention.
    O'Malley TL; Hawk ME; Egan JE; Krier SE; Burke JG
    AIDS Behav; 2020 May; 24(5):1342-1357. PubMed ID: 31776819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CHARISMA Randomized Controlled Trial: A Relationship-Focused Counseling Intervention Integrated Within Oral PrEP Delivery for HIV Prevention Among Women in Johannesburg, South Africa.
    Montgomery ET; Roberts ST; Reddy K; Tolley EE; Hartmann M; Mathebula F; Wagner LD; Lanham M; Wilcher R; Browne EN; Baeten JM; Palanee-Phillips T
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):425-433. PubMed ID: 35416797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educating men about vaginal microbicides: considerations from Kenya.
    Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
    Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
    BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of vaginal microbicides among female sex workers and their intimate male partners in two Mexico-US border cities: a mixed methods analysis.
    Robertson AM; Syvertsen JL; Martinez G; Rangel MG; Palinkas LA; Stockman JK; Ulibarri MD; Strathdee SA
    Glob Public Health; 2013; 8(5):619-33. PubMed ID: 23398385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
    Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
    AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
    J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.